Oral submucous fibrosis: pathogenesis and therapeutic approaches

Abstract Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix (ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a chronic, progressive fibrosis disease. However, despite some advancements in recent years, no targeted antifibro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianfei Tang, Junjie Liu, Zekun Zhou, Xinyan Cui, Hua Tu, Jia Jia, Baike Chen, Xiaohan Dai, Ousheng Liu
Format: Article
Language:English
Published: Nature Publishing Group 2025-02-01
Series:International Journal of Oral Science
Online Access:https://doi.org/10.1038/s41368-024-00344-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571958959538176
author Jianfei Tang
Junjie Liu
Zekun Zhou
Xinyan Cui
Hua Tu
Jia Jia
Baike Chen
Xiaohan Dai
Ousheng Liu
author_facet Jianfei Tang
Junjie Liu
Zekun Zhou
Xinyan Cui
Hua Tu
Jia Jia
Baike Chen
Xiaohan Dai
Ousheng Liu
author_sort Jianfei Tang
collection DOAJ
description Abstract Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix (ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a chronic, progressive fibrosis disease. However, despite some advancements in recent years, no targeted antifibrotic strategies for OSF have been approved; likely because the complicated mechanisms that initiate and drive fibrosis remain to be determined. In this review, we briefly introduce the epidemiology and etiology of OSF. Then, we highlight how cell-intrinsic changes in significant structural cells can drive fibrotic response by regulating biological behaviors, secretion function, and activation of ECM-producing myofibroblasts. In addition, we also discuss the role of innate and adaptive immune cells and how they contribute to the pathogenesis of OSF. Finally, we summarize strategies to interrupt key mechanisms that cause OSF, including modulation of the ECM, inhibition of inflammation, improvement of vascular disturbance. This review will provide potential routes for developing novel anti-OSF therapeutics.
format Article
id doaj-art-d15b6fe7d30a43bc82cdecd7644d6088
institution Kabale University
issn 2049-3169
language English
publishDate 2025-02-01
publisher Nature Publishing Group
record_format Article
series International Journal of Oral Science
spelling doaj-art-d15b6fe7d30a43bc82cdecd7644d60882025-02-02T12:11:30ZengNature Publishing GroupInternational Journal of Oral Science2049-31692025-02-0117111510.1038/s41368-024-00344-6Oral submucous fibrosis: pathogenesis and therapeutic approachesJianfei Tang0Junjie Liu1Zekun Zhou2Xinyan Cui3Hua Tu4Jia Jia5Baike Chen6Xiaohan Dai7Ousheng Liu8Hunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityHunan Key Laboratory of Oral Health Research & Hunan 3D Printing Engineering Research Center of Oral Care & Hunan Clinical Research Center of Oral Major Diseases and Oral Health & Academician Workstation for Oral-Maxilofacial and Regenerative Medicine & Xiangya Stomatological Hospital & Xiangya School of Stomatology, Central South UniversityAbstract Oral submucous fibrosis (OSF), characterized by excessive deposition of extracellular matrix (ECM) that causes oral mucosal tissue sclerosis, and even cancer transformation, is a chronic, progressive fibrosis disease. However, despite some advancements in recent years, no targeted antifibrotic strategies for OSF have been approved; likely because the complicated mechanisms that initiate and drive fibrosis remain to be determined. In this review, we briefly introduce the epidemiology and etiology of OSF. Then, we highlight how cell-intrinsic changes in significant structural cells can drive fibrotic response by regulating biological behaviors, secretion function, and activation of ECM-producing myofibroblasts. In addition, we also discuss the role of innate and adaptive immune cells and how they contribute to the pathogenesis of OSF. Finally, we summarize strategies to interrupt key mechanisms that cause OSF, including modulation of the ECM, inhibition of inflammation, improvement of vascular disturbance. This review will provide potential routes for developing novel anti-OSF therapeutics.https://doi.org/10.1038/s41368-024-00344-6
spellingShingle Jianfei Tang
Junjie Liu
Zekun Zhou
Xinyan Cui
Hua Tu
Jia Jia
Baike Chen
Xiaohan Dai
Ousheng Liu
Oral submucous fibrosis: pathogenesis and therapeutic approaches
International Journal of Oral Science
title Oral submucous fibrosis: pathogenesis and therapeutic approaches
title_full Oral submucous fibrosis: pathogenesis and therapeutic approaches
title_fullStr Oral submucous fibrosis: pathogenesis and therapeutic approaches
title_full_unstemmed Oral submucous fibrosis: pathogenesis and therapeutic approaches
title_short Oral submucous fibrosis: pathogenesis and therapeutic approaches
title_sort oral submucous fibrosis pathogenesis and therapeutic approaches
url https://doi.org/10.1038/s41368-024-00344-6
work_keys_str_mv AT jianfeitang oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT junjieliu oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT zekunzhou oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT xinyancui oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT huatu oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT jiajia oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT baikechen oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT xiaohandai oralsubmucousfibrosispathogenesisandtherapeuticapproaches
AT oushengliu oralsubmucousfibrosispathogenesisandtherapeuticapproaches